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1. ANALISA STATISTIK 
 
Explore 
[DataSet1] D:\KTI BIOKIM\selisih.sav 




Valid Missing Total 
N Percent N Percent N Percent 
Kadar Bilirubin 




    Statistic Std. Error 
Kadar Bilirubin 
Sebelum Perlakuan 
Mean ,2714 ,01347 
95% Confidence 
Interval for Mean 
Lower Bound ,2438   
Upper Bound 
,2991   
5% Trimmed Mean ,2683   
Median ,3000   
Variance ,005   
Std. Deviation ,07127   
Minimum ,20   
Maximum ,40   
Range ,20   
Interquartile Range ,10   
Skewness ,486 ,441 
Kurtosis -,830 ,858 
 
 




Statistic Df Sig. Statistic df Sig. 
Kadar Bilirubin 
Sebelum Perlakuan ,270 28 ,000 ,784 28 ,000 













Valid Missing Total 
N Percent N Percent N Percent 




    Statistic Std. Error 
pre_trans Mean -,5805 ,02126 
95% Confidence 
Interval for Mean 
Lower Bound -,6241   
Upper Bound 
-,5369   
5% Trimmed Mean -,5841   
Median -,5229   
Variance ,013   
Std. Deviation ,11248   
Minimum -,70   
Maximum -,40   
Range ,30   
Interquartile Range ,18   
Skewness ,187 ,441 
Kurtosis -1,359 ,858 
 




Statistic df Sig. Statistic df Sig. 
pre_trans ,282 28 ,000 ,780 28 ,000 





















  kelompok perlakuan N Mean Rank 
Kadar Bilirubin 
Sebelum Perlakuan 
kontrol 5 8,90 
P1 6 20,50 
P2 6 10,50 
P3 6 16,50 
P4 5 15,30 
Total 28   
 









Asymp. Sig. ,069 
a  Kruskal Wallis Test 
b  Grouping Variable: kelompok perlakuan 
 





  kelompok perlakuan   Statistic Std. Error 
Kadar Bilirubin 
Sebelum Perlakuan 
kontrol Mean ,2200 ,02000 
95% Confidence 
Interval for Mean 
Lower Bound ,1645   
Upper Bound 
,2755   
5% Trimmed Mean ,2167   
Median ,2000   
Variance ,002   
Std. Deviation ,04472   
Minimum ,20   
 kelompok perlakuan 
Cases 
Valid Missing Total 
N Percent N Percent N Percent 
Kadar Bilirubin 
Sebelum Perlakuan 
kontrol 5 100,0% 0 ,0% 5 100,0% 
P1 6 100,0% 0 ,0% 6 100,0% 
P2 6 100,0% 0 ,0% 6 100,0% 
P3 6 100,0% 0 ,0% 6 100,0% 
P4 5 100,0% 0 ,0% 5 100,0% 
45 
Maximum ,30   
Range ,10   
Interquartile Range ,05   
Skewness 2,236 ,913 
Kurtosis 5,000 2,000 
P1 Mean ,3333 ,03333 
95% Confidence 
Interval for Mean 
Lower Bound ,2476   
Upper Bound 
,4190   
5% Trimmed Mean ,3370   
Median ,3500   
Variance ,007   
Std. Deviation ,08165   
Minimum ,20   
Maximum ,40   
Range ,20   
Interquartile Range ,13   
Skewness -,857 ,845 
Kurtosis -,300 1,741 
P2 Mean ,2333 ,02108 
95% Confidence 
Interval for Mean 
Lower Bound ,1791   
Upper Bound 
,2875   
5% Trimmed Mean ,2315   
Median ,2000   
Variance ,003   
Std. Deviation ,05164   
Minimum ,20   
Maximum ,30   
Range ,10   
Interquartile Range ,10   
Skewness ,968 ,845 
Kurtosis -1,875 1,741 
P3 Mean ,2833 ,01667 
95% Confidence 
Interval for Mean 
Lower Bound ,2405   
Upper Bound 
,3262   
5% Trimmed Mean ,2870   
Median ,3000   
Variance ,002   
Std. Deviation ,04082   
Minimum ,20   
Maximum ,30   
Range ,10   
Interquartile Range ,03   
Skewness -2,449 ,845 
Kurtosis 6,000 1,741 
46 
P4 Mean ,2800 ,03742 
95% Confidence 
Interval for Mean 
Lower Bound ,1761   
Upper Bound 
,3839   
5% Trimmed Mean ,2778   
Median ,3000   
Variance ,007   
Std. Deviation ,08367   
Minimum ,20   
Maximum ,40   
Range ,20   
Interquartile Range ,15   
Skewness ,512 ,913 
Kurtosis -,612 2,000 
 
 Tests of Normality 
 
  kelompok perlakuan 
Kolmogorov-Smirnov(a) Shapiro-Wilk 
Statistic df Sig. Statistic df Sig. 
Kadar Bilirubin 
Sebelum Perlakuan 
kontrol ,473 5 ,001 ,552 5 ,000 
P1 ,293 6 ,117 ,822 6 ,091 
P2 ,407 6 ,002 ,640 6 ,001 
P3 ,492 6 ,000 ,496 6 ,000 
P4 ,231 5 ,200(*) ,881 5 ,314 
*  This is a lower bound of the true significance. 





[DataSet1] D:\KTI BIOKIM\selisih.sav 




Valid Missing Total 
N Percent N Percent N Percent 
Kadar Bilirubin 




    Statistic Std. Error 
Kadar Bilirubin 
Sesudah Perlakuan 
Mean 1,0786 ,11505 
95% Confidence 
Interval for Mean 
Lower Bound ,8425   
Upper Bound 
1,3146   
5% Trimmed Mean 1,0230   
Median ,8500   
47 
Variance ,371   
Std. Deviation ,60880   
Minimum ,40   
Maximum 2,90   
Range 2,50   
Interquartile Range ,73   
Skewness 1,523 ,441 
Kurtosis 1,877 ,858 
 




Statistic Df Sig. Statistic df Sig. 
Kadar Bilirubin 
Sesudah Perlakuan ,266 28 ,000 ,817 28 ,000 




[DataSet3] D:\KTI BIOKIM\POSTTEST.sav 




Valid Missing Total 
N Percent N Percent N Percent 
POST_TRANS2 28 100,0% 0 ,0% 28 100,0% 
 Descriptives 
 
    Statistic Std. Error 
POST_TRANS2 Mean 1,0538 ,04569 
95% Confidence 
Interval for Mean 
Lower Bound ,9600   
Upper Bound 
1,1475   
5% Trimmed Mean 1,0519   
Median 1,0861   
Variance ,058   
Std. Deviation ,24174   
Minimum ,59   
Maximum 1,58   
Range ,99   
Interquartile Range ,35   
Skewness -,091 ,441 












Statistic df Sig. Statistic df Sig. 
POST_TRANS2 ,143 28 ,147 ,961 28 ,366 








Statistic df1 df2 Sig. 









Squares df Mean Square F Sig. 
Between Groups ,359 4 ,090 1,696 ,185 
Within Groups 1,218 23 ,053     




  Kelompok Perlakuan   Statistic Std. Error 
Kadar Bilirubin Serum 
Setelah Perlakuan 
Kontrol Mean 1,6400 ,41183 
95% Confidence 
Interval for Mean 
Lower Bound ,4966   
Upper Bound 
2,7834   
5% Trimmed Mean 1,6222   
Median 1,7000   
Variance ,848   
Std. Deviation ,92087   
Minimum ,70   
Maximum 2,90   
Range 2,20   
Interquartile Range 1,75   
Skewness ,360 ,913 
Kurtosis -1,318 2,000 
P1 Mean ,8500 ,20936 
95% Confidence 
Interval for Mean 
Lower Bound ,3118   
Upper Bound 
1,3882   
5% Trimmed Mean ,8222   
Median ,7000   
49 
Variance ,263   
Std. Deviation ,51284   
Minimum ,40   
Maximum 1,80   
Range 1,40   
Interquartile Range ,73   
Skewness 1,581 ,845 
Kurtosis 2,604 1,741 
P2 Mean ,8000 ,05164 
95% Confidence 
Interval for Mean 
Lower Bound ,6673   
Upper Bound 
,9327   
5% Trimmed Mean ,7944   
Median ,7500   
Variance ,016   
Std. Deviation ,12649   
Minimum ,70   
Maximum 1,00   
Range ,30   
Interquartile Range ,23   
Skewness ,889 ,845 
Kurtosis -,781 1,741 
P3 Mean ,9500 ,14549 
95% Confidence 
Interval for Mean 
Lower Bound ,5760   
Upper Bound 
1,3240   
5% Trimmed Mean ,9444   
Median ,9000   
Variance ,127   
Std. Deviation ,35637   
Minimum ,50   
Maximum 1,50   
Range 1,00   
Interquartile Range ,63   
Skewness ,497 ,845 
Kurtosis -,159 1,741 
P4 Mean 1,2800 ,31048 
95% Confidence 
Interval for Mean 
Lower Bound ,4180   
Upper Bound 
2,1420   
5% Trimmed Mean 1,2556   
Median ,9000   
Variance ,482   
Std. Deviation ,69426   
Minimum ,70   
Maximum 2,30   
Range 1,60   
50 
Interquartile Range 1,25   
Skewness ,965 ,913 





[DataSet1] D:\KTI BIOKIM\selisih.sav 




Statistic df Sig. Statistic df Sig. 
Peningkatan 
Kadar Bilirubin ,274 28 ,000 ,822 28 ,000 




  kelompok perlakuan   Statistic Std. Error 
Peningkatan 
Kadar Bilirubin 
Kontrol Mean 1,4200 ,42356 










Spread vs. Level Plot of posttest by kelompok
* Plot of LN of Spread vs LN of Level
Slope = 1,562 Power for transformation = -,562
51 
Interval for Mean Upper Bound 
2,5960   
5% Trimmed Mean 1,4056   
Median 1,5000   
Variance ,897   
Std. Deviation ,94710   
Minimum ,40   
Maximum 2,70   
Range 2,30   
Interquartile Range 1,80   
Skewness ,292 ,913 
Kurtosis -1,363 2,000 
P1 Mean ,5167 ,20883 
95% Confidence 
Interval for Mean 
Lower Bound -,0202   
Upper Bound 
1,0535   
5% Trimmed Mean ,4852   
Median ,3500   
Variance ,262   
Std. Deviation ,51153   
Minimum ,10   
Maximum 1,50   
Range 1,40   
Interquartile Range ,65   
Skewness 1,873 ,845 
Kurtosis 3,745 1,741 
P2 Mean ,5667 ,04944 
95% Confidence 
Interval for Mean 
Lower Bound ,4396   
Upper Bound 
,6938   
5% Trimmed Mean ,5574   
Median ,5000   
Variance ,015   
Std. Deviation ,12111   
Minimum ,50   
Maximum ,80   
Range ,30   
Interquartile Range ,15   
Skewness 1,952 ,845 
Kurtosis 3,657 1,741 
P3 Mean ,6667 ,15202 
95% Confidence 
Interval for Mean 
Lower Bound ,2759   
Upper Bound 
1,0575   
5% Trimmed Mean ,6630   
Median ,6000   
Variance ,139   
52 
Std. Deviation ,37238   
Minimum ,20   
Maximum 1,20   
Range 1,00   
Interquartile Range ,70   
Skewness ,392 ,845 
Kurtosis -,943 1,741 
P4 Mean 1,0000 ,28983 
95% Confidence 
Interval for Mean 
Lower Bound ,1953   
Upper Bound 
1,8047   
5% Trimmed Mean ,9722   
Median ,7000   
Variance ,420   
Std. Deviation ,64807   
Minimum ,50   
Maximum 2,00   
Range 1,50   
Interquartile Range 1,15   
Skewness 1,148 ,913 













Statistic df Sig. Statistic df Sig. 
selisih_trans ,164 28 ,051 ,961 28 ,369 



















Spread vs. Level Plot of selisih by kelompok
* Plot of LN of Spread vs LN of Level
Slope = 1,096 Power for transformation = -,096 
54 
Oneway 
[DataSet1] D:\KTI BIOKIM\selisih.sav 




Statistic df1 df2 Sig. 







Squares df Mean Square F Sig. 
Between Groups ,794 4 ,198 2,259 ,094 
Within Groups 2,020 23 ,088     





    Statistic Std. Error 
preK Mean ,2200 ,02000 
95% Confidence 
Interval for Mean 
Lower Bound ,1645   
Upper Bound 
,2755   
5% Trimmed Mean ,2167   
Median ,2000   
Variance ,002   
Std. Deviation ,04472   
Minimum ,20   
Maximum ,30   
Range ,10   
Interquartile Range ,05   
Skewness 2,236 ,913 
Kurtosis 5,000 2,000 
postK Mean 1,6400 ,41183 
95% Confidence 
Interval for Mean 
Lower Bound ,4966   
Upper Bound 
2,7834   
5% Trimmed Mean 1,6222   
Median 1,7000   
Variance ,848   
Std. Deviation ,92087   
Minimum ,70   
Maximum 2,90   
Range 2,20   
Interquartile Range 1,75   
55 
Skewness ,360 ,913 
Kurtosis -1,318 2,000 
preP4 Mean ,2800 ,03742 
95% Confidence 
Interval for Mean 
Lower Bound ,1761   
Upper Bound 
,3839   
5% Trimmed Mean ,2778   
Median ,3000   
Variance ,007   
Std. Deviation ,08367   
Minimum ,20   
Maximum ,40   
Range ,20   
Interquartile Range ,15   
Skewness ,512 ,913 
Kurtosis -,612 2,000 
postP4 Mean 1,2800 ,31048 
95% Confidence 
Interval for Mean 
Lower Bound ,4180   
Upper Bound 
2,1420   
5% Trimmed Mean 1,2556   
Median ,9000   
Variance ,482   
Std. Deviation ,69426   
Minimum ,70   
Maximum 2,30   
Range 1,60   
Interquartile Range 1,25   
Skewness ,965 ,913 
Kurtosis -1,002 2,000 
 




Statistic df Sig. Statistic df Sig. 
preK ,473 5 ,001 ,552 5 ,000 
postK ,219 5 ,200(*) ,930 5 ,595 
preP4 ,231 5 ,200(*) ,881 5 ,314 
postP4 ,308 5 ,137 ,851 5 ,197 
*  This is a lower bound of the true significance. 









Wilcoxon Signed Ranks Test 
 Ranks 
 
    N Mean Rank Sum of Ranks 
postK - preK Negative Ranks 0(a) ,00 ,00 
Positive Ranks 5(b) 3,00 15,00 
Ties 0(c)     
Total 5     
a  postK < preK 
b  postK > preK 




 Test Statistics(b) 
 
  postK - preK 
Z -2,023(a) 
Asymp. Sig. (2-tailed) ,043 
a  Based on negative ranks. 
b  Wilcoxon Signed Ranks Test 
 
T-Test 
 Paired Samples Statistics 
 
  Mean N Std. Deviation 
Std. Error 
Mean 
Pair 1 preP4 ,2800 5 ,08367 ,03742 
postP4 1,2800 5 ,69426 ,31048 
 





    Statistic Std. Error 
preP1 Mean ,3333 ,03333 
95% Confidence 
Interval for Mean 
Lower Bound ,2476   
Upper Bound 
,4190   
5% Trimmed Mean ,3370   
Median ,3500   
Variance ,007   
 
Paired Differences t df Sig. (2-tailed) 
Mean Std. Deviation 
Std. Error 
Mean 
95% Confidence Interval 
of the Difference Mean Std. Deviation 
Std. Error 
Mean 
Lower Upper Lower Upper Lower Upper Lower Upper 
Pair 1 preP4 - postP4 -1,00000 ,64807 ,28983 -1,80469 -,19531 -3,450 4 ,026 
57 
Std. Deviation ,08165   
Minimum ,20   
Maximum ,40   
Range ,20   
Interquartile Range ,13   
Skewness -,857 ,845 
Kurtosis -,300 1,741 
postp1 Mean ,8500 ,20936 
95% Confidence 
Interval for Mean 
Lower Bound ,3118   
Upper Bound 
1,3882   
5% Trimmed Mean ,8222   
Median ,7000   
Variance ,263   
Std. Deviation ,51284   
Minimum ,40   
Maximum 1,80   
Range 1,40   
Interquartile Range ,73   
Skewness 1,581 ,845 
Kurtosis 2,604 1,741 
prep2 Mean ,2333 ,02108 
95% Confidence 
Interval for Mean 
Lower Bound ,1791   
Upper Bound 
,2875   
5% Trimmed Mean ,2315   
Median ,2000   
Variance ,003   
Std. Deviation ,05164   
Minimum ,20   
Maximum ,30   
Range ,10   
Interquartile Range ,10   
Skewness ,968 ,845 
Kurtosis -1,875 1,741 
postp2 Mean ,8000 ,05164 
95% Confidence 
Interval for Mean 
Lower Bound ,6673   
Upper Bound 
,9327   
5% Trimmed Mean ,7944   
Median ,7500   
Variance ,016   
Std. Deviation ,12649   
Minimum ,70   
Maximum 1,00   
Range ,30   
Interquartile Range ,23   
58 
Skewness ,889 ,845 
Kurtosis -,781 1,741 
prep3 Mean ,2833 ,01667 
95% Confidence 
Interval for Mean 
Lower Bound ,2405   
Upper Bound 
,3262   
5% Trimmed Mean ,2870   
Median ,3000   
Variance ,002   
Std. Deviation ,04082   
Minimum ,20   
Maximum ,30   
Range ,10   
Interquartile Range ,03   
Skewness -2,449 ,845 
Kurtosis 6,000 1,741 
postp3 Mean ,9500 ,14549 
95% Confidence 
Interval for Mean 
Lower Bound ,5760   
Upper Bound 
1,3240   
5% Trimmed Mean ,9444   
Median ,9000   
Variance ,127   
Std. Deviation ,35637   
Minimum ,50   
Maximum 1,50   
Range 1,00   
Interquartile Range ,63   
Skewness ,497 ,845 
Kurtosis -,159 1,741 
 




Statistic df Sig. Statistic df Sig. 
preP1 ,293 6 ,117 ,822 6 ,091 
postp1 ,218 6 ,200(*) ,851 6 ,162 
prep2 ,407 6 ,002 ,640 6 ,001 
postp2 ,285 6 ,138 ,831 6 ,110 
prep3 ,492 6 ,000 ,496 6 ,000 
postp3 ,222 6 ,200(*) ,966 6 ,867 
*  This is a lower bound of the true significance. 







 Paired Samples Statistics 
 
  Mean N Std. Deviation 
Std. Error 
Mean 
Pair 1 preP1 ,3333 6 ,08165 ,03333 
postp1 ,8500 6 ,51284 ,20936 
 
 Paired Samples Test 
 
  
Paired Differences t df Sig. (2-tailed) 
Mean Std. Deviation 
Std. Error 
Mean 
95% Confidence Interval 
of the Difference Mean Std. Deviation 
Std. Error 
Mean 
Lower Upper Lower Upper Lower Upper Lower Upper 






Wilcoxon Signed Ranks Test 
 Ranks 
 
    N Mean Rank Sum of Ranks 
postp2 - prep2 Negative Ranks 0(a) ,00 ,00 
Positive Ranks 6(b) 3,50 21,00 
Ties 0(c)     
Total 6     
a  postp2 < prep2 
b  postp2 > prep2 
c  postp2 = prep2 
 






Asymp. Sig. (2-tailed) ,024 
a  Based on negative ranks. 







Wilcoxon Signed Ranks Test 
 Ranks 
 
    N Mean Rank Sum of Ranks 
postp3 - prep3 Negative Ranks 0(a) ,00 ,00 
Positive Ranks 6(b) 3,50 21,00 
Ties 0(c)     
Total 6     
a  postp3 < prep3 
b  postp3 > prep3 
c  postp3 = prep3 
 






Asymp. Sig. (2-tailed) ,027 
a  Based on negative ranks. 



































































Kadar Total Bilirubin Serum Sebelum Perlakuan  
Kelompok Kadar Bilirubin Total (mg/dl) 
Kontrol 0,2;0,3;0,2;0,2;0,2;0,2 
Perlakuan 1 0,3;0,3;0,4;0,2;0,4,;0,4 
Perlakuan 2 0,2;0,3;0,2;0,2;0,3;0,2 
Perlakuan 3 0,3;0,3;0,3;0,3;0,3;0,2 
Perlakuan 4 0,3;0,4;0,2;0,2;0,2;0,3 
 
Kadar Total Bilirubin Setelah Perlakuan 
Kelompok Kadar Total Bilirubin 
Kontrol 2,1;0,7;0,8;1,7;2,9 
Perlakuan 1 1,8;0,4;0,6;0,5;0,8;1 
Perlakuan 2 0,7;0,9;0,7;0,7;0,8;1 
Perlakuan 3 0,9;1,5;0,5;0,9;0,7;1,2 
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Jenis kelamin  : Perempuan 
Alamat  : Jalan Lampersari no 43 Semarang 
Nomor Telepon : 024-8315784 
Nomor HP  : 081325789871 
e-mail   : aninditamustika@yahoo.com 
Riwayat Pendidikan Formal 
1. SD  : SDN Sompok 01 Semarang  Lulus tahun : 2004 
2. SMP  : SMPN 3 Semarang   Lulus tahun : 2007 
3. SMA : SMAN 3 Semarang   Lulus tahun : 2009 
4. FK UNDIP : Masuk tahun 2009 
 
 
 
 
 
 
